Imunon, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Imunon, Inc. (IMNN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$60.80 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-03-31
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-09-30 was $0.00.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-06-30 was -$133.10K, a 448.72% decline year-over-year.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2024-03-31 was $72.31K, a 25.75% decline year-over-year.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$60.80K, a 277.24% decline from fiscal 2023.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $34.30K, a 0.48% decline from fiscal 2022.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $34.47K.
- Imunon, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$7.97K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | -$133.10K derived: sum of 3 quarters · filed 2026-03-31 | -$60.80K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$133.10K derived: sum of 2 quarters · filed 2025-08-05 | -$60.80K 10-Q · filed 2024-11-07 | -$20.43K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-06-30 | -$133.10K 10-Q · filed 2025-08-05 | -$60.80K 10-Q · filed 2025-08-05 | -$20.43K derived: sum of 3 quarters · filed 2025-08-05 | -$162.04K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $72.31K 10-Q · filed 2025-05-12 | $112.67K derived: sum of 2 quarters · filed 2025-05-12 | -$28.94K derived: sum of 3 quarters · filed 2025-05-12 | $9.22K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $40.36K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$101.25K derived: sum of 2 quarters · filed 2025-02-27 | -$63.08K derived: sum of 3 quarters · filed 2025-02-27 | $34.30K 10-K · filed 2025-02-27 |
| 2023-09-30 | -$141.61K 10-Q · filed 2024-11-07 | -$103.44K derived: sum of 2 quarters · filed 2024-11-07 | -$6.06K 10-Q · filed 2024-11-07 | $45.86K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $38.17K 10-Q · filed 2024-08-14 | $135.55K 10-Q · filed 2024-08-14 | $187.47K derived: sum of 3 quarters · filed 2024-08-14 | $232.08K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $97.38K 10-Q · filed 2024-05-13 | $149.30K derived: sum of 2 quarters · filed 2024-05-13 | $193.91K derived: sum of 3 quarters · filed 2024-05-13 | $182.85K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $51.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $96.53K derived: sum of 2 quarters · filed 2024-03-28 | $85.47K derived: sum of 3 quarters · filed 2024-03-28 | $34.47K 10-K · filed 2024-03-28 |
| 2022-09-30 | $44.61K 10-Q · filed 2023-11-14 | $33.55K derived: sum of 2 quarters · filed 2023-11-14 | -$17.45K 10-Q · filed 2023-11-14 | -$27.56K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$11.06K 10-Q · filed 2023-08-10 | -$62.06K 10-Q · filed 2023-08-10 | -$72.17K derived: sum of 3 quarters · filed 2023-08-10 | -$66.26K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$51.00K 10-Q · filed 2023-05-11 | -$61.12K derived: sum of 2 quarters · filed 2023-05-11 | -$55.21K derived: sum of 3 quarters · filed 2023-05-11 | -$60.76K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$10.11K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$4.20K derived: sum of 2 quarters · filed 2023-03-30 | -$9.76K derived: sum of 3 quarters · filed 2023-03-30 | -$7.97K 10-K · filed 2023-03-30 |
| 2021-09-30 | $5.91K 10-Q · filed 2022-11-14 | $354.00 derived: sum of 2 quarters · filed 2022-11-14 | $2.14K 10-Q · filed 2022-11-14 | $2.14K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$5.55K 10-Q · filed 2022-08-15 | -$3.77K 10-Q · filed 2022-08-15 | -$3.77K derived: sum of 3 quarters · filed 2022-08-15 | -$11.64K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.78K 10-Q · filed 2022-05-16 | $1.78K derived: sum of 2 quarters · filed 2022-05-16 | -$6.08K derived: sum of 3 quarters · filed 2022-05-16 | -$2.03K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$7.87K derived: sum of 2 quarters · filed 2022-03-31 | -$3.81K derived: sum of 3 quarters · filed 2022-03-31 | -$42.78K 10-K · filed 2022-03-31 |
| 2020-09-30 | -$7.87K 10-Q · filed 2021-11-15 | -$3.81K derived: sum of 2 quarters · filed 2021-11-15 | -$42.78K 10-Q · filed 2021-11-15 | -$34.08K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $4.05K 10-Q · filed 2021-08-12 | -$34.91K 10-Q · filed 2021-08-12 | -$26.21K derived: sum of 3 quarters · filed 2021-08-12 | -$86.71K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$38.97K 10-Q · filed 2021-05-14 | -$30.26K derived: sum of 2 quarters · filed 2021-05-14 | -$90.76K derived: sum of 3 quarters · filed 2021-05-14 | -$83.01K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $8.70K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | -$51.80K derived: sum of 2 quarters · filed 2021-03-19 | -$44.05K derived: sum of 3 quarters · filed 2021-03-19 | $12.91K 10-K · filed 2021-03-19 |
| 2019-09-30 | -$60.50K 10-Q · filed 2020-11-16 | -$52.75K derived: sum of 2 quarters · filed 2020-11-16 | $4.20K 10-Q · filed 2020-11-16 | $13.12K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $7.75K 10-Q · filed 2020-08-14 | $64.70K 10-Q · filed 2020-08-14 | $73.62K derived: sum of 3 quarters · filed 2020-08-14 | $98.82K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $56.95K 10-Q · filed 2020-05-15 | $65.86K derived: sum of 2 quarters · filed 2020-05-15 | $91.07K derived: sum of 3 quarters · filed 2020-05-15 | $120.24K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $8.91K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $34.12K derived: sum of 2 quarters · filed 2020-03-25 | $63.29K derived: sum of 3 quarters · filed 2020-03-25 | $40.04K 10-K · filed 2020-03-25 |
| 2018-09-30 | $25.21K 10-Q · filed 2019-11-14 | $54.37K derived: sum of 2 quarters · filed 2019-11-14 | $31.12K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $29.17K 10-Q · filed 2019-08-14 | $5.92K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$23.25K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$10.16K 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $3.86K 10-K · filed 2018-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |